Evidence map›Paper›PMID 11748181›Full record

ArticleInfection and immunity2002

Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice.

Lawrence L Johnson, Peter C Sayles

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 95 citations in OpenAlex.

  1. The live attenuatedResearch square · 2026
    Article
  2. Lymphotoxin beta receptorInfection and immunity · 2025
    Article
  3. Toxoplasma gondii and the Brain: Frenemies? Or Just Outright Foes?Journal of the Pediatric Infectious Diseases Society · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Key Limitations and New Insights Into theFrontiers in cellular and infection microbiology · 2020
    Review
  9. Review
  10. A latent ability to persist: differentiation in Toxoplasma gondii.Cellular and molecular life sciences : CMLS · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. RecombinantFrontiers in cellular and infection microbiology · 2017
    Article
  15. Induction of Protective Immunity againstFrontiers in microbiology · 2017
    Article
  16. The effect of chitosan nanospheres on the immunogenicity of Toxoplasma lysate vaccine in mice.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lawrence L JohnsonTrudeau Institute, Inc., Saranac Lake, New York 12983, USA. ljohnson@trudeauinstitute.org
Peter C Sayles
Trudeau Institute · US

Funding

B CELL DEPENDENT IMMUNITY TO TOXOPLASMA GONDIIR01AI046571 · NIAID · TRUDEAU INSTITUTE, INC. · PI JOHNSON, LAWRENCE L. · 2000 to 2004
$1.9M
NIAID NIH HHS AI-46571NIAID NIH HHS R01 AI046571
6 · The paper itself

Abstract

Resistance to infection with Toxoplasma gondii was studied in mice lacking CD4 expression. Such mice developed more brain cysts and survived for a shorter time than did wild-type controls after peroral infection with ME49 cysts. After immunization with the ts-4 strain of T. gondii, CD4-deficient mice exhibited impaired resistance to a challenge infection with virulent RH tachyzoites. Thus, deficient CD4 expression increases the susceptibility of mice to a primary peroral T. gondii infection with cysts and impairs their ability to be successfully vaccinated. CD8(+) T cells from blood or spleens of Toxoplasma-infected, CD4-deficient mice expressed markers of activation at frequencies similar to those of infected wild-type mice. Production of IFN-gamma in vitro was moderately depressed, and levels of Toxoplasma-specific immunoglobulin G2a in serum were substantially lower than in wild-type mice. Administration of Toxoplasma-immune serum to ts-4-vaccinated CD4-deficient mice significantly improved their resistance to RH challenge. Also, the survival of CD4-deficient mice chronically infected with ME49 was significantly prolonged by administration of immune serum. These results demonstrate that in addition to CD8(+) T cells and IFN-gamma, which are known to be critical for resistance, CD4(+) cells also contribute significantly to protection against chronic T. gondii infections and against challenge infections with highly virulent tachyzoites in immunized mice via their role as helper cells for production of isotype-switched antibodies.

Indexed as

AnimalsAntibodies, ProtozoanAntibody FormationCD4 AntigensCD8-Positive T-LymphocytesCells, CulturedChronic DiseaseDisease SusceptibilityFemaleImmunity, InnateImmunoglobulin GInterferon-gammaInterleukin-12Lymphocyte ActivationMaleMiceAntibodies, ProtozoanCD4 AntigensImmunoglobulin GInterferon-gammaInterleukin-12Protozoan Vaccines

Identifiers

PMID11748181
PMCPMC127596
OpenAlexW2098679813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.